Clinical Study of Enoxacin in the Treatment of Urinary Tract Infections: A Comparison with Pipemidic Acid

Kouno K. , Inoue M. , Mitsuhashi S. : In vitro and in vivo antibacterial activity of AT-2266. Chemotherapy (Tokyo), 32; Suppl. 3; 1–17 (1984).

Goto S. , Tsuji A. , Ogawa M. , Kaneko Y. , Miyazaki S. , Muto Y. , Kuwabara S. : In vitro and in vivo antibacterial activities of AT-2266. A new pyridonecarboxylic acid antibacterial agent. Chemotherapy (Tokyo), 32, Suppl. 3; 19–33 (1984).

Tsuchida S. , Harada T. , Nishizawa O. , Takeda H. , Noto H. , Mori H. : Clinical study of AT-2266 in urinary tract infections. Chemotherapy (Tokyo), 32, Suppl. 3; 646–657 (1984).

Saito I. , Terada Y. , Yokozawa M. , Ono K. : Clinical evaluation of AT-2266 in urinary tract infection. Chemotherapy (Tokyo), 32, Suppl. 3; 689–702(1984).

Miyamoto S. , Tamiya T. , Takatsuka K. , Kumamoto Y. : Clinical evaluation of AT-2266 in urinary tract infections. Chemotherapy (Tokyo), 32, Suppl. 3; 639–645 (1984).

Tanaka K. , Nihira H. , Oda S. : Clinical experiences of pipemidic acid in complicated urinary tract infections. Chemotherapy (Tokyo), 29; 3110–3114 (1975).

Kawamura N. , Ohkoshi M. , Ishikawa H. , Ohhara A. : Die klinische Erfahrung über pipemidische Saere für urogenitale Infektionen. Chemotherapy (Tokyo), 23; 3020–3024 (1975).